United States - English - NLM (National Library of Medicine)

asegua therapeutics llc - ledipasvir (unii: 013te6e4wv) (ledipasvir - unii:013te6e4wv), sofosbuvir (unii: wj6ca3zu8b) (sofosbuvir - unii:wj6ca3zu8b) - ledipasvir and sofosbuvir is indicated for the treatment of adults and pediatric patients 3 years of age and older with chronic hepatitis c virus (hcv) [see dosage and administration (2.2 and 2.3) and clinical studies (14)]: - genotype 1, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis - genotype 1 infection with decompensated cirrhosis, for use in combination with ribavirin - genotype 1 or 4 infection who are liver transplant recipients without cirrhosis or with compensated cirrhosis, for use in combination with ribavirin if ledipasvir and sofosbuvir is administered with ribavirin, the contraindications to ribavirin also apply to this combination regimen. refer to the ribavirin prescribing information for a list of contraindications for ribavirin [see dosage and administration (2.2)] . risk summary if ledipasvir and sofosbuvir is administered with ribavirin, the combination regimen is contraindicated in pregnant women and in men whose female partners are pregnant. refer to the ribavirin

Israel - English - Ministry of Health

gilead sciences israel ltd - sofosbuvir - film coated tablets - sofosbuvir 400 mg - sofosbuvir - sovaldi is indicated in combination with other medicinal products for the treatment of chronic hepatitis c (chc) in adults.for hepatitis c virus (hcv) genotype specific activity, see physician leaflet .

Israel - English - Ministry of Health

gilead sciences israel ltd - sofosbuvir - film coated tablets - sofosbuvir 400 mg - sofosbuvir - sovaldi is indicated in combination with other medicinal products for the treatment of chronic hepatitis c (chc) in adults.for hepatitis c virus (hcv) genotype specific activity, see physician leaflet .

Israel - English - Ministry of Health

gilead sciences israel ltd - sofosbuvir - film coated tablets - sofosbuvir 400 mg - sofosbuvir - sovaldi is indicated in combination with other medicinal products for the treatment of chronic hepatitis c (chc) in adults.for hepatitis c virus (hcv) genotype specific activity, see physician leaflet .

Kenya - English - Pharmacy and Poisons Board

mylan laboratories limited mylan laboratories limited plot no.564/a/22, road - sofosbuvir - film-coated tablet - each film coated tablets contains: sofosbuvir 400… - sofosbuvir

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

gilead sciences malaysia sdn. bhd. - sofosbuvir; velpatasvir -

Israel - English - Ministry of Health

gilead sciences israel ltd - sofosbuvir; velpatasvir; voxilaprevir - film coated tablets - voxilaprevir 100 mg; velpatasvir 100 mg; sofosbuvir 400 mg - sofosbuvir, velpatasvir and voxilaprevir - vosevi is indicated for the treatment of chronic hepatitis c virus (hcv) infection in adults.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

mylan healthcare sdn. bhd. - velpatasvir; sofosbuvir -

Israel - English - Ministry of Health

gilead sciences israel ltd - sofosbuvir; velpatasvir - film coated tablets - velpatasvir 100 mg; sofosbuvir 400 mg - sofosbuvir - epclusa is indicated for the treatment of chronic hepatitis c virus (hcv) infection in adults.

Israel - English - Ministry of Health

gilead sciences israel ltd - sofosbuvir; velpatasvir - film coated tablets - velpatasvir 100 mg; sofosbuvir 400 mg - sofosbuvir - epclusa is indicated for the treatment of chronic hepatitis c virus (hcv) infection in adults.